Greg Poorman is a Senior Research Analyst in Strategic Market Access, located in Pharmerit’s New York office. Prior to joining Pharmerit, Greg was a research associate at a major pharmaceutical company creating market access materials to support products from launch to post-LOE, supporting real world evidence studies and clinical trials, conducting literature reviews and meta-analysis, and utilizing commercial and government claims databases.
Greg also worked as a fellow at NYU Hospital for Joint Diseases where he supported the team as a statistician and medical writer completing over 65 peer-reviewed manuscripts, 2 book chapters, and receiving a 2016 Cervical Spine Research Society grant and the North American Spine Society 2017 Value award. His research interests include orthopedics, CNS, pain, and health economics and outcomes research. Greg earned a BA in Biological Sciences from Cornell University and an MPH in Health Care Policy Analysis and Management from New York University.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.